The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Am J Psychiatry 163:689-696, April 2006
doi: 10.1176/appi.ajp.163.4.689
© 2006 American Psychiatric Association
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Hasin, D.
* Articles by Waxman, R.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Hasin, D.
* Articles by Waxman, R.
Related Collections
* Opioids
* Other Addictive Disorders
* Anxiety Disorders (General)
* Eating Disorders
* Depression
* Alcohol
* Antisocial Personality Disorders
* Borderline Personality Disorders
* Schizophrenia Spectrum Disorders
* Amphetamines
* DSM
* Diagnostic Criteria
* Interviews
* Cannabis
* Cocaine
* Hallucinogens

Diagnosis of Comorbid Psychiatric Disorders in Substance Users Assessed With the Psychiatric Research Interview for Substance and Mental Disorders for DSM-IV

Deborah Hasin, Ph.D., Sharon Samet, M.S.W., Edward Nunes, M.D., Jakob Meydan, Psy.D., Karen Matseoane, B.A., and Rachel Waxman, B.A.

OBJECTIVE: The authors used the Psychiatric Research Interview for Substance and Mental Disorders for DSM-IV (PRISM-IV) to test the reliability of DSM-IV-defined disorders, including primary and substance-induced disorders, in substance-abusing subjects. METHOD: Substance-abusing patients (N=285) from substance abuse/dual-diagnosis treatment settings and mental health treatment settings participated in test and blind retest interviews with the PRISM-IV, which includes specific guidelines for assessment of substance abusers. RESULTS: Kappas for primary and substance-induced major depressive disorder ranged from 0.66 to 0.75. Reliability for psychotic disorders, eating disorders, antisocial personality disorder, and borderline personality disorder was in the same range. Reliability for most anxiety disorders was lower. Reliability was good to excellent (kappas ≥0.65) for most substance dependence disorders. Continuous measures (severity, age at onset) had intraclass correlation coefficients >0.70 with few exceptions. Reliability was better for primary than for substance-induced disorders, although not greatly so. CONCLUSION: Most DSM-IV psychiatric disorders can be assessed in substance-abusing subjects with acceptable to excellent reliability by using specifically designed procedures. Good reliability improves the likelihood of significant study results.




This article has been cited by other articles:


Home page
Br. J. PsychiatryHome page
C. L. M. CATON, D. S. HASIN, P. E. SHROUT, R. E. DRAKE, B. DOMINGUEZ, M. B. FIRST, S. SAMET, and B. SCHANZER
Stability of early-phase primary psychotic disorders with concurrent substance use and substance-induced psychosis
The British Journal of Psychiatry, February 1, 2007; 190(2): 105 - 111.
[Abstract] [Full Text] [PDF]


Home page
Psychiatr. Serv.Home page
B. M. Schanzer, M. B. First, B. Dominguez, D. S. Hasin, and C. L. M. Caton
Diagnosing Psychotic Disorders in the Emergency Department in the Context of Substance Use
Psychiatr Serv, October 1, 2006; 57(10): 1468 - 1473.
[Abstract] [Full Text] [PDF]


Home page
Schizophr BullHome page
C. L. M. Caton, D. S. Hasin, P. E. Shrout, R. E. Drake, B. Dominguez, S. Samet, and B. Schanzer
Predictors of Psychosis Remission in Psychotic Disorders That Co-occur With Substance Use
Schizophr Bull, October 1, 2006; 32(4): 618 - 625.
[Abstract] [Full Text] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 2006 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org